VNO
52
2
VZ
39
2
LOW
45
2
ETN
61
2
CPB
37
2
XYL
35
2
LNC
70
-2
NVDA
57
-2
MU
79
3
PSA
37
2
STI
15
-6
NWL
57
3
SJM
14
3
ADT
48
2
PG
43
2
DIS
72
2
NKE
36
6
KIM
56
5
AAPL
55
2
SWKS
56
8
VNO
52
2
VZ
39
2
LOW
45
2
ETN
61
2
CPB
37
2
XYL
35
2
LNC
70
-2
NVDA
57
-2
MU
79
3
PSA
37
2
STI
15
-6
NWL
57
3
SJM
14
3
ADT
48
2
PG
43
2
DIS
72
2
NKE
36
6
KIM
56
5
AAPL
55
2
SWKS
56
8
Financhill
Back

Cintas Corp. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
42

CTAS
Cintas Corp.

Last Price:
$191.07
Seasonality Move:
4.87%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
42
Cintas Corp. (CTAS) is a Sell

Is Cintas Corp. a Buy, Sell or Hold?

  • The current Cintas Corp. [CTAS] share price is $191.18. The Score for CTAS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CTAS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CTAS Stock Price Chart

What is Cintas Corp.'s stock price today?

  • The Cintas Corp. share price today is $191.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTAS is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CTAS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.09 Buy
Relative Strength Index (14 RSI): 58.17 Buy
Chaikin Money Flow: 279404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (183.55 - 188.99) Buy
Bollinger Bands (100): (184.26 - 209.54) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CTAS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 189.34 Buy
20-day SMA: 186.92 Buy
50-day SMA: 186.65 Buy
200-day SMA: 205.31 Sell
8-day EMA: 189.49 Buy
20-day EMA: 187.81 Buy
50-day EMA: 189.23 Buy
200-day EMA: 199.06 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Cintas Corp. Earnings Growth & CTAS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.01 per share, an increase this year of $0.68 per share, and an increase next year of $0.46 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Cintas Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):